Article ID Journal Published Year Pages File Type
8317910 Clinical Biochemistry 2012 6 Pages PDF
Abstract
► We assessed serum markers of liver fibrosis / inflammation during entecavir therapy. ► Most serum markers improved in patients with hepatitis B during entecavir therapy. ► Procollagen III N-terminal peptide is an independent predictor of HBeAg loss.
Keywords
Related Topics
Life Sciences Biochemistry, Genetics and Molecular Biology Biochemistry
Preview
Changes in serum histologic surrogate markers and procollagen III N-terminal peptide as independent predictors of HBeAg loss in patients with chronic hepatitis B during entecavir therapy
Authors
, , , , , , , , , , ,